US › Healthcare

Eledon Pharmaceuticals Inc (ELDN)

US · Healthcare · Biotechnology

$3.49+1.75%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$0
Net profit
$-39.0M
Profit YoY
-500.8%
EPS
$-0.33
EPS estimate
$-0.26

EPS came in at -0.33 against a street estimate of -0.26 — a miss of 26.9%.

Key statistics

Market cap
$264.8M
Forward P/E
5.4
P/B
5.83
Book value
$1.32
EPS (TTM)
$-0.77
52-week high
$4.60
52-week low
$1.35
50-day MA
$3.76
200-day MA
$2.90
Beta
0.96

Analyst view

Analysts rate Eledon Pharmaceuticals Inc a strong buy (6 buy, 0 hold, 0 sell out of 6) with an average price target of $9.00.

Shareholding

Insiders
0.04%
Institutions
59.92%

Largest institutional holders

FundStake
Bvf Inc8.15%
BlackRock Inc5.68%
Vanguard Group Inc5.23%
Defilade Capital Management, L.P.4.62%
Vanguard Capital Management, LLC4.27%
Ensign Peak Advisors Inc3.19%
Zimmer Partners LP2.43%
Geode Capital Management, LLC2.32%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Eledon Pharmaceuticals Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.